==== Front Iran J Basic Med Sci Iran J Basic Med Sci IJBMS Iranian Journal of Basic Medical Sciences 2008-3866 2008-3874 Mashhad University of Medical Sciences Mashhad, Iran 10.22038/IJBMS.2023.68801.14995 Original Article Therapeutic effects of diosgenin on alveolar bone loss and apoptosis in diabetic rats with experimental periodontitis Kızıldağa Alper 1* Alpanb Aysan Lektemür 1 Özdedec Melih 2 Aydınd Tuğba 3 Özmene Özlem 4 1 Department of Periodontology, Faculty of Dentistry, Pamukkale University, Denizli, Turkey 2 Department of Dentomaxillofacial Radiology, Faculty of Dentistry, Dokuz Eylül University, İzmir, Turkey 3 Department of Periodontology, Faculty of Dentistry, Atatürk University, Erzurum, Turkey 4 Department of Veterinary Pathology, Faculty of Veterinary Medicine, Burdur Mehmet Akif Ersoy University, Burdur, Turkey * Corresponding author: Alper Kızıldağ. Pamukkale University, Faculty of Dentistry, Department of Periodontology, 20070, Denizli, Turkey, Tel: 0258 296 42 24, Fax: +90 258 296 17 63; Email: alperkizildag@hotmail.com 2023 26 7 785790 4 11 2022 15 3 2023 https://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Objective(s): The present study aims to evaluate the efficacy of administered diosgenin (DG) which has anti-oxidant and anti-inflammatory effects, on alveolar bone loss (ABL) and apoptosis in diabetic rats with periodontitis. Materials and Methods: Forty male Wistar albino rats (n=40) were divided into five subgroups; control (non-ligated), periodontitis (P), diabetes mellitus (DM), P+DM, and P+DM+DG. To stimulate experimental periodontitis, a ligature was embedded at the gingival margin of the lower first molars for each rat, and diabetes was induced by streptozotocin (STZ) for DM groups. Then, DG (96 mg/kg daily) was performed on the P+DM+DG group by oral gavage for 29 days. At day 30, all animals were euthanized and the distance from the cement-enamel junction to the alveolar bone margin was measured using cone-beam computed tomography as ABL. In addition, immunohistochemical analyses were used to evaluate the expression levels of alkaline phosphatase (ALP), osteocalcin (OCN), bone morphogenetic protein 2 (BMP-2), receptor activator of NF-κB ligand (RANKL), collagen type I (Col-1), B-cell lymphoma-2 (Bcl-2), and Bcl-2-associated X protein (Bax). Results: Induction of periodontitis and diabetes significantly increased ABL (P<0.05). DG administration significantly reduced ABL, expression of RANKL and Bax, and enhanced the expression of ALP, OCN, BMP-2, Bcl-2, and Col-1 in the P+DM+DG group compared with the P+DM group (P<0.05). Conclusion: It is revealed that DG considerably enhanced bone formation and contributed to periodontal healing in this experimental study performed in diabetic rats. Key Words Alveolar bone loss Anti-oxidant Diabetes mellitus Experimental Periodontitis Therapeutics ==== Body pmcIntroduction Diabetes is a serious chronic disease that results from insulin insufficiency or deficiency. Poorly controlled or uncontrolled diabetes increases the severity of periodontal disease; hence, periodontitis is recognized as a major complication of diabetes (1, 2). Similarly, severe periodontal disease worsens glycemic control and outcomes in patients with diabetes over time (3-5). Periodontitis is a chronic inflammatory disease caused by an imbalance between the resident commensal oral bacterial complex and host-associated oral microbiome dysbiosis. Non-treatment of periodontal inflammation results in the loss of hard and soft tissues due to host-mediated destruction (6). Various mechanisms such as oxidative stress and receptor activator of NF-κB ligand (RANKL) activation play a role in periodontal destruction. In terms of health, reactive oxygen species support the antimicrobial defense system by helping eliminate pathogenic oral bacteria and modulating the gene regulators and cell signaling pathways (7, 8). However, an excessive increase in reactive oxygen species poses a danger to the tissue because reactive oxygen species activate the apoptotic pathways by increasing the expression of B-cell lymphoma-2 (Bcl-2)-associated X (Bax) pro-apoptotic proteins and impair the mitochondria of cells (9). Additionally, high reactive oxygen species levels cause osteoclast cell formation by inducing the expression of RANKL (10). Produced as a membrane-bound or released ligand by activated T- and B-cells, osteoblasts, and fibroblasts, RANKL is a key factor in bone resorption. It promotes osteoclast differentiation and leads to RANKL-related osteoclastogenesis in tissues (10, 11). Gingival crevicular fluid and gingival tissue from patients with periodontal disease demonstrate a higher RANKL expression than those from periodontally healthy patients (12, 13). Several studies linking diabetes with RANKL expression indicated that poor glycemic control provokes RANKL expression (14, 15). Furthermore, diabetes increases the release of RANKL by promoting and prolonging inflammation (15, 16). Bone morphogenetic proteins (BMPs), which are growth factors, belong to the transforming growth factor-β superfamily and play a major role in the differentiation, migration, proliferation, and apoptosis of cells. BMP-2 is commonly used to enhance tissue healing in the dental field (17). It modulates the maturation of mesenchymal stem cells into osteoblast cells and thus promotes bone formation (18). Moreover, BMP-2 regulates the maturation of osteoblast cells via secretion of osteocalcin (OCN), osteopontin, alkaline phosphatase (ALP), and collagen type I (Col-1) (19, 20). Diosgenin (DG) is a naturally occurring steroid saponin and has strong pharmacokinetic effects. In particular, it has anti-oxidant, anti-inflammatory, and glucose-lowering effects (21-23). DG may prevent alveolar bone loss (ABL) by stimulating the signaling of the BMP and Wnt pathways, inhibiting apoptosis, and regulating the expression of RANKL and OCN (24-27). However, despite these properties, no study has yet evaluated the effect of DG in diabetic rats with periodontitis. We hypothesized that DG may promote bone healing and decrease the destructive effects of diabetes and periodontitis on the alveolar bone by regulating oxidative stress, inflammation, and apoptosis. Therefore, we evaluated the effects of DG in a rat model of diabetes and ABL using cone-beam computed tomography (CBCT) and immunohistochemistry. Materials and Methods Animals All experimental procedures were conducted in accordance with the University Ethics Committee for Animal Experiments (PAUHADYEK- 2018/34). The study protocol was created in accordance with the ARRIVE Guidelines (Animal Research: Reporting of In Vivo Experiments). Forty male Wistar albino rats (age: 4 months, weight: 350–400 g) were included in the present study. To adapt to the environment, all animals were kept separately in cages under standard laboratory conditions (21±2 °C and 12 hr light:12 hr dark cycle) for 10 days and provided free access to pellet-shaped food and water. The rats were randomly and equally divided into five subgroups: control (non-ligated, n=8), periodontitis (P) (ligature only, n=8), diabetes mellitus (DM) (streptozotocin [STZ] only, n=8), P+DM (ligature+DM, n=8), and P+DM+DG (ligature+DM+DG, n=8). Based on a previous study, DG (Sigma-Aldrich, Saint Louis, MO, USA) was dissolved in distilled water and administered at 96 mg/kg/daily to the P+DM+DG group (26) via oral gavage for 29 days. The animals were sacrificed on the 30th day under general anesthesia. Periodontitis Periodontitis was induced under anesthesia via administration of 50 mg/kg body weight of ketamine (Eczacibasi Ilac Sanayi, Istanbul, Turkey) and 5 mg/kg body weight of xylazine chloride (Virbaxil, São Paulo, Brazil) intraperitoneally. A sterile silk suture (4-0, Dogsan Ilac Sanayi, Istanbul, Turkey) was embedded in the cervical region of the first lower left and right mandibular molars, and the suture was kept at the submarginal position to induce bacterial and plaque accumulation, inflammation, bone loss, and periodontitis. The same operator (AK) evaluated the ligature positions every day. The first lower left molars were used for CBCT measurements and the first lower right molars for histopathological evaluations. Diabetes induction The blood glucose level and weight of all animals were determined before the experimental procedure and sacrifice. Experimental diabetes was induced in the DM, P+DM, and P+DM+DG groups using STZ (Sigma-Aldrich). STZ was dissolved in 0.01 M citrate buffer at a pH of 4.5 and injected 50 mg/kg body weight intraperitoneally. Three days after STZ injection, blood samples were obtained from the tail vein, and the blood glucose levels were evaluated using an Accu-Chek Active glucometer (Roche Diagnostics, Mannheim, Germany). The rats with blood glucose levels of >300 mg/dl were considered diabetic (28). The blood glucose levels were measured weekly in the STZ-treated rats throughout the course of the experiment. On day 30, all rats were euthanized via intravenous injection of 150 mg/kg pentobarbital sodium (Oak Pharmaceuticals, Inc., Lake Forest, IL, USA) for tissue collection. Imaging procedure For three-dimensional (3D) imaging, a supine-positioned CBCT device (Newtom 5G-XL; QR, Verona, Italy) was used. To obtain a better image quality, we selected the smallest field of view (6×6 cm). The exposure conditions were as follows: 100 mm voxel, 110 kV, 11.4 mA, 9.0 sec exposure time, 26.0 s scanning time, enhanced scan, boosted dose, and high-resolution mode. For standardization of imaging procedures, all samples were handled in the same exposure settings and positions. The original NNT software (version 12.1; QR, Verona, Italy) was used to conduct 3D analysis. A 10-year experienced dentomaxillofacial radiologist (MO) blinded to the samples performed all imaging procedures and analyzed the images. ABL was measured from the cemento-enamel junction to the alveolar bone crest, averaging six areas (mesial–medial–distal of the buccal–lingual surfaces) of the first left mandibular molars (Figure 2). Histopathological methods The obtained right mandibular specimens were fixed in 10% neutral-buffered formalin for histopathological evaluation. The specimens were decalcified in a solution (Osteofast 1, Biognost, Zagreb, Croatia) for 2 weeks, and the solution was changed twice a week. Thereafter, decalcified mandibular tissues were routinely processed using automatic tissue processor equipment (Leica ASP300S; Leica Microsystems, Wetzlar, Germany) and soaked in paraffin. Subsequently, the specimens were cut along the long axis of the tooth in the mesiodistal direction, and serial 5 μm sections were taken using a rotary microtome (Leica RM 2155; Leica Microsystems) from each sample. The 5 μm sections were then stained with hematoxylin and eosin. All histopathological procedures were performed using a light microscope by an experienced researcher (ÖÖ) who was blinded to the study specimen. Histopathological evaluations were performed at ×40 magnification and in accordance with histopathological scoring criteria. Inflammatory cell infiltration, alveolar bone resorption, and cementum degeneration and destruction were evaluated as previously described (29). score 0: absence of or only discrete cellular infiltration and preserved alveolar process and cementum; score 1: hyperemia, moderate cellular infiltration in the gingival tissue, some but minor alveolar process resorption, and intact cementum; score 2: hyperemia, accentuated cellular infiltration in the gingival/periodontal tissue, accentuated degradation of the alveolar process, and partial destruction of the cementum; and score 3: hyperemia, diffuse cellular infiltration in the gingival/periodontal tissue, ulceration at the gingival epithelium, complete resorption of the alveolar process, and severe destruction of the cementum. Immunohistochemical methods Following the manufacturer’s instructions, the sections were stained with the following antibodies: BMP-2 (anti-BMP-2 antibody; ab59348, Abcam plc, Cambridge, UK), RANKL (anti-RANKL antibody; ab216484, Abcam plc), ALP (anti-ALP antibody; ab224335, Abcam plc), Bax (anti-Bax antibody; ab53154, Abcam plc), Bcl-2 (anti-Bcl-2 antibody; ab59348, Abcam plc), Col-1 (Col-1 antibody; ab34710, Abcam plc), and OCN (anti-OCN antibody; ab93876, Abcam plc). This procedure was performed using the streptavidin–biotin–peroxidase technique. For all primary antibodies, 1/100 dilution was used. The Mouse and Rabbit Specific HRP/DAB Detection Kit-Micropolymer (ab236466, Abcam plc) was utilized for the secondary antibody, and 3,3′-diaminobenzidine was used as the chromogen. The primary antibody was disregarded in the negative controls. All immunohistochemical analyses were conducted by a specialized pathologist (ÖÖ) who was blinded to the samples. Seven serial sections were arranged and evaluated for each animal and were scored semiquantitatively by considering the staining intensity as described previously (0, absence of staining; 1, slight staining; 2, medium staining; and 3, marked staining) (19). Subsequently, computer-assisted histomorphometric and immunohistochemical assessments were performed using an automated image analysis system (Olympus CX41; Olympus Corporation, Tokyo, Japan). The lesioned area was analyzed using the Database Manual CellSens Life Science Imaging Software System (Olympus Corporation). Statistical analysis The required study sample size was 8 for the groups with periodontitis to reach a statistical power of 90%. The Shapiro–Wilk test was used to measure data normality. Data on ABL were analyzed using the post hoc Duncan multiple comparisons test and one-way analysis of variance. The Kruskal–Wallis test along with post hoc Mann–Whitney U test with Bonferroni correction was used to compare the independent variables (ALP, Bax, Bcl-2, BMP-2, Col-1, OCN, and RANKL expressions and histopathological scores). Data on ABL were reported as means±SDs (P<0.05) and data on immunohistochemical proteins as ranges and medians. All analyses were performed using SPSS version 23 (IBM Corporation, NY, USA). Results CBCT findings CBCT revealed that the ligature induced ABL in all sutured groups. ABL in the P+DM group was significantly greater than that in the P group (P<0.05). ABL was significantly less in the P+DM+DG group than in the P and P+DM groups (P<0.05; Figures 1 and 2). Histopathological findings Normal gingival epithelium and gingival tissue architecture and no pathological findings were detected in the control group. Hyperemia, ulceration at the gingival epithelial layer, inflammatory activities in the gingival and periodontal tissues, partial to severe corruption of the cement, and marked deterioration of the alveolar process were observed in the P, P+DM, and P+DM+DG groups. Meanwhile, the P+DM+DG group showed reduced pathological findings of periodontitis (cellular infiltration in the gingiva and periodontal ligament, alveolar bone destruction, and cement corruption) compared with P and P+DM groups (Figure 3). Immunohistochemical findings Immunohistochemical staining revealed the expression of ALP, Bcl-2, Bax, Col-1, OCN, RANKL, and BMP-2 in the mesenchymal cells of all groups. Brown color was used to indicate positive immunoexpression. In the control group, a slight to negative expression of ALP, Bcl-2, Bax, Col-1, OCN, RANKL, and BMP-2 was observed (Figure 3). The expression of ALP, Bcl-2, BMP-2, Col-1, and OCN significantly decreased in the P group compared with that in the control group (P<0.05). The P+DM group showed a significantly reduced expression of ALP, Bcl-2, BMP-2, and OCN compared with the DM group (P<0.05). In contrast, the P+DM+DG group had a significantly increased expression of ALP, Bcl-2, BMP-2, Col-1, and OCN compared with P and P+DM groups (P<0.05). The statistical analysis results are shown in Table 1. The expression of Bax and RANKL significantly increased in P and P+DM groups compared with that in the control group (P<0.05). The P+DM+DG group showed significantly decreased RANKL and Bax expressions compared with P and P+DM groups (P<0.05). The expression of RANKL and Bax in all groups is shown in Table 1. Discussion To our knowledge, this study is the first to report the therapeutic effects of DG on ABL in diabetic rats with periodontitis based on histomorphometric, immunohistochemical, and CBCT findings. Several previous studies have evaluated the effects of different doses of DG on bone loss (26, 27). These studies suggested that a high dose of DG significantly modulates bone formation, inhibits bone resorption, and regulates bone metabolism compared with a low dose of DG. Based on a previous study, 96 mg/kg of DG was used to investigate the effect of DG on bone loss in the present study (26). Micro-computed tomography is considered the gold standard method for the evaluation of periodontal and bone defects. However, it has a high radiation dose and is therefore not performed routinely in clinical practice (30). Thereby, studies have begun to focus on CBCT as an alternative to micro-computed tomography. Kulah et al. measured the smallest voxel size using CBCT to evaluate the maxillary trabecular microstructure and detected a significant correlation between micro-computed tomography and CBCT findings (30). ABL has been previously evaluated using CBCT in experimental periodontitis (19). In an in vitro study, CBCT was found to be an efficient modality in the assessment of periodontal defects (31). Therefore, CBCT was used to evaluate ABL in the current study. Type 1 diabetes is a chronic autoimmune disease in which a subclass of T lymphocytes induces apoptosis of pancreatic β cells (32). STZ has been used in several studies to induce diabetes (28). It damages the pancreas and decreases the β cell mass, inducing type 1 diabetes. STZ-induced diabetes is a suitable model for elucidating the mechanisms of diabetes-associated pathogenesis (33). Hence, we used STZ to induce diabetes in this study. Advanced glycation end products could stimulate apoptosis and oxidative stress in human periodontal ligament cells (34). Furthermore, diabetes and periodontitis significantly increase apoptosis in diabetic rats with periodontitis (28). Bax is a proapoptotic cell and a member of the Bcl-2 family. Bax and Bcl-2 act as stimulators and inhibitors of apoptosis, respectively (19, 28). The expression of Bax and Bcl-2 was then used to evaluate apoptosis in the present study. Herein, the presence of periodontitis and diabetes alone and in combination significantly decreased the expression of Bcl-2 and induced that of Bax. However, DG significantly reduced the expression of Bax and increased that of Bcl-2. DG has also been reported to ameliorate apoptosis in diabetic rats (24). These results suggest that DG may modulate periodontitis and diabetes-related apoptosis by regulating the expression of Bax and Bcl-2 (24). Several studies have examined RANKL to evaluate the mechanism of the destructive effect of diabetes and periodontitis on the alveolar bone. They demonstrated that periodontitis and diabetes provoke the expression of RANKL and thereby increase alveolar bone destruction (16, 28, 35). Zhang et al. (26) showed that DG reduces bone loss in ovariectomized rats by modulating RANKL expression. In the present study, DG significantly decreased the expression of RANKL in the P+DM+DG group compared with that in the P and P+DM groups. Similarly, ABL was significantly reduced in the P+DM+DG group compared with that in P and P+DM groups. Accordingly, DG may prevent bone loss by inhibiting the expression of RANKL, confirming previous findings (26). The bone continues to form and resorb throughout life. Various growth factors, cytokines, and signaling pathways, including ALP, OCN, Col-1, and BMP-2, are required for the stability of bone metabolism (36). ALP is a critical biomarker of bone formation and can reflect osteoblast cell activity (27). OCN is an essential marker of bone formation and remodeling because it controls mineral deposition (37). Meanwhile, Col-1 promotes osteoblast cell differentiation and mineral matrix accumulation (38). Alpan et al. (28) reported that periodontitis and diabetes significantly decreased the expression of ALP, OCN, Col-1, and BMP-2 in rats. Accordingly, we investigated the efficacy of DG in bone metabolism by evaluating the expression of ALP, OCN, BMP-2, and Col-1. A study indicated that DG modulates bone metabolism and hence stimulates bone formation and prevents bone resorption (27). In an in vitro study, arginyl–DG conjugate promoted osteoblastic differentiation by inducing BMP-2 and ALP activity (39). Other in vitro studies indicated that DG significantly increases the expression of ALP and OCN (40). Our study demonstrated that the DG-treated group showed a significantly increased expression of ALP, OCN, and Col-1 compared with the disease groups. Similarly, BMP-2 has great potential in stimulating bone formation (18). DG modulates the signaling of the Wnt and BMP pathways, which regulate the osteogenic differentiation of mesenchymal stem cells or preosteoblasts. Thereby, DG induces bone formation (25). Herein, the DG-treated group showed a significantly increased BMP-2 expression compared with the disease groups. The present findings suggest that DG stimulates bone formation by enhancing the expression of ALP, OCN, Col-1, and BMP-2, consistent with previous reports (25, 27, 39, 40). The present study has some limitations, including non-evaluation of the expression of OPG and RANKL/OPG. We also did not assess the total anti-oxidant capacity to examine tissue inflammation and performed only hematoxylin and eosin staining. Additionally, the therapeutic effects of DG on ABL were determined via CBCT analysis only. Figure 1 Cone-beam computed tomography measurements of alveolar bone loss of study groups All values were expressed as mean±SD P: Periodontitis, DM: Diabetes mellitus, DG: Diosgenin a Statistically significant difference (P<0.05) between the control and the others b Statistically significant difference (P<0.05) between P and the others c Statistically significant difference (P<0.05) between DM and the others. d Statistically significant difference (P<0.05) between P+DM and the others e Statistically significant difference (P<0.05) between P+DM+DG and the others Figure 2 Cone-beam computed tomography images from all study groups The left and middle columns show three-dimensional reconstruction images of the buccal and lingual areas, respectively; the right column shows cross-sectional images. C: Control P: Periodontitis, DM: Diabetes mellitus, DG: Diosgenin Figure 3 Histopathological sight and immunohistochemical expression of study groups Normal gingival histology in the control group (arrow); gingival epithelial loss and severe inflammatory reaction in the P group, nearly normal appearance of gingiva in the DM group; severe inflammatory reaction, ulceration, and alveolar bone loss in the P+DM group and decreased inflammatory reaction and periodontal lesions and increased epithelization in the P+DM+DG group. T: teeth; the bars represent 100 µm., P: Periodontitis, DM: Diabetes mellitus Table 1 Statistical analysis results of immunohistochemical scores of study groups Groups Control P DM P+DM P+DM+DG min-max (median) min-max (median) min-max (median) min-max (median) min-max (median) Histopathological Scores 0−0(0)b,c,d,e 2−3(2)a,c,e 0−1(1)a,b,d 2−3(3)a,c,e 1−2(2)a,b,d ALP 1-3 (2) b,c,d 0-1 (0) a,c,e 0-2 (1) a,b,d,e 0-1 (0) a,c,e 1-3 (2) a,b,d OCN 2-3 (3) b,c,d,e 0-1 (1) a,c,e 1-2 (1) a,b,d 0-1 (0) a,c,e 1-3 (2) a,b,d BMP-2 0-2 (2) b,d,e 0-1 (0) a,c,e 0-1 (1) b,d,e 0-1 (0) a,c,e 1-3 (2) a,b,c,d Col-1 2-3 (3) b,c,d 0-1 (0) a,e 0-2 (1) a,e 0-1 (0) a,e 1-3 (2) b,c,d RANKL 0-1 (0) b,c,d,e 2-3 (2) a,c,e 0-2 (1) a,b,d 1-3 (2) a,c,e 0-2 (1) a,b,d Bax 0-1 (0) b,c,d 1-3 (3) a,e 1-3 (2) a,e 2-3 (2) a,e 1-2 (1) b,c,d Bcl-2 1-3 (2) b,c,d 0-2 (1) a,c,e 1-2 (1) a,b,d,e 0-1 (0) a,c,e 1-3 (3) b,c,d Conclusion It can be concluded that as a natural product with anti-inflammatory activities, DG regulates the pathological effects of periodontitis by increasing the expression of BMP-2, ALP, OCN, and Col-1 and reducing the expression of RANKL, apoptosis, and ABL. Future studies need to compare CBCT with micro-computed tomography and evaluate different parameters, including the Wnt/β-catenin pathway, to further elucidate the mechanism of DG. Authors’ Contributions AK and TA designed the study. AK and ALA applied the experimental procedures. MÖ applied radiographic analyses. ÖÖ performed ımmunohistochemical analyses. ALA carried out the statistical analyses. AK wrote the manuscript. Conflicts of Interest The authors report no conflict of interest. Acknowledgment This study was self-funded by the authors. ==== Refs References 1 Löe H Periodontal disease: the sixth complication of diabetes mellitus Diabetes Care 1993 16 329 334 8422804 2 Kocher T König J Borgnakke WS Pink C Meisel P Periodontal complications of hyperglycemia/diabetes mellitus: epidemiologic complexity and clinical challenge Periodontol 2018 78 59 97 3 Borgnakke WS Ylöstalo PV Taylor GW Genco RJ Effect of periodontal disease on diabetes: Systematic review of epidemiologic observational evidence J Periodontol 2013 84 S135 S152 23631574 4 Graziani F Gennai S Solini A Petrini M A systematic review and meta-analysis of epidemiologic observational evidence on the effect of periodontitis on diabetes An update of the EFP-AAP review J Clin Periodontol 2018 45 167 187 29277926 5 Genco RJ Graziani F Hasturk H Effects of periodontal disease on glycemic control, complications, and incidence of diabetes mellitus Periodontol 2020 83 59 65 6 Van Dyke TE Sima C Understanding resolution of inflammation in periodontal diseases: is chronic inflammatory periodontitis a failure to resolve? Periodontol 2020 82 205 213 7 Sczepanik FSC Grossi ML Casati M Goldberg M Glogauer M Fine N Periodontitis is an inflammatory disease of oxidative stress: We should treat it that way Periodontol 2020 84 45 68 8 Wang GP Defining functional signatures of dysbiosis in periodontitis progression Genome Med 2015 7 1 3 25606059 9 Yee YH Chong SJF Pervaiz S The anti-oxidant and pro-oxidant dichotomy of Bcl-2 Biol Chem 2016 397 585 593 27060742 10 Arabacı T Kermen E Özkanlar S Köse O Kara A Kızıldağ A Therapeutic effects of melatonin on alveolar bone resorption after experimental periodontitis in rats: A biochemical and immunohistochemical study J Periodontol 2015 86 874 881 25812911 11 Tobón-Arroyave SI Isaza-Guzmán DM Restrepo-Cadavid EM Zapata-Molina SM Martínez-Pabón MC Association of salivary levels of the bone remodelling regulators sRANKL and OPG with periodontal clinical status J Clin Periodontol 2012 39 1132 1140 23039038 12 Kawai T Matsuyama T Hosokawa Y Makihira S Seki M Karimbux NY B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease Am J Clin Pathol 2006 169 987 998 13 Bostanci N İlgenli T Emingil G Afacan B Han B Töz H Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: Implications of their relative ratio J Clin Periodontol 2007 34 370 376 17355365 14 Santos VR Lima JA Gonçalves TED Bastos MF Figueiredo LC Shibli JA Receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in sites of chronic periodontitis of subjects with poorly and well-controlled type 2 diabetes J Periodontol 2010 81 1455 1465 20476881 15 Vieira Ribeiro F de Mendonça AC Santos VR Bastos MF Figueiredo LC Duarte PM Cytokines and bone-related factors in systemically healthy patients with chronic periodontitis and patients with type 2 diabetes and chronic periodontitis J Periodontol 2011 82 1187 1196 21284550 16 Graves DT Alshabab A Albiero ML Mattos M Corrêa JD Chen S Osteocytes play an important role in experimental periodontitis in healthy and diabetic mice through expression of RANKL J Clin Periodontol 2018 45 285 292 29220094 17 Kaigler D Avila G Wisner-Lynch L Nevins ML Nevins M Rasperini G Platelet-derived growth factor applications in periodontal and peri-implant bone regeneration Expert Opin Biol Ther 2011 11 375 385 21288185 18 Devescovi V Leonardi E Ciapetti G Cenni E Growth factors in bone repair Chir Organi Mov 2008 92 161 168 19043663 19 Alpan AL Kızıldağ A Özdede M Karakan NC Özmen Ö The effects of taxifolin on alveolar bone in experimental periodontitis in rats Arch Oral Biol 2020 117 104823 32593876 20 Hashimi SM Exogenous noggin binds the BMP-2 receptor and induces alkaline phosphatase activity in osteoblasts J Cell Biochem 2019 120 13237 13242 30887565 21 Ma MH Wu XH He Y Huang W Anti-inflammatory and analgesic effects of saponins from D Zingiberensis CH Wright and diosgenin derivative on mice Sichuan Da Xue Xue Bao Yi Xue Ban. 2011 42 494 497 21866633 22 Pari L Monisha P Jalaludeen AM Beneficial role of diosgenin on oxidative stress in aorta of streptozotocin induced diabetic rats Eur J Pharmacol 2012 691 143 150 22771295 23 Son IS Kim JH Sohn HY Son KH Kim JS Kwon CS Anti-oxidative and hypolipidemic effects of diosgenin, a steroidal saponin of yam (Dioscorea spp on high-cholesterol fed rats Biosci Biotechnol Biochem 2007 71 3063 3071 18071250 24 Khosravi Z Sedaghat R Baluchnejadmojarad T Roghani M Diosgenin ameliorates testicular damage in streptozotocin-diabetic rats through attenuation of apoptosis, oxidative stress, and inflammation Int Immunopharmacol 2019 70 37 46 30785089 25 Zhang Z Chen Y Xiang L Wang Z Xiao GG Ju D Diosgenin protects against alveolar bone loss in ovariectomized rats via regulating long noncoding RNAs Exp Ther Med 2018 16 3939 3950 30344672 26 Zhang Z Song C Fu X Liu M Li Y Pan J High-dose diosgenin reduces bone loss in ovariectomized rats via attenuation of the RANKL/OPG ratio Int J Mol Sci 2014 15 17130 17147 25257532 27 Zhao S Niu F Xu CY Liu Y Ye L Bi GB Diosgenin prevents bone loss on retinoic acid-induced osteoporosis in rats Ir J Med Sci 2016 185 581 587 26089290 28 Alpan AL Bakar O Kızıldağ A Özdede M Topsakal Ş Özmen Ö Effects of taxifolin on bone formation and apoptosis in experimental periodontitis in diabetic rats Biotech Histochem 2021 1 9 32362148 29 Leitão R Ribeiro R Chaves H Rocha F Lima V Brito G Nitric oxide synthase inhibition prevents alveolar bone resorption in experimental periodontitis in rats J Periodontol 2005 76 956 963 15948691 30 Kulah K Gulsahi A Kamburoğlu K Geneci F Ocak M Celik HH Evaluation of maxillary trabecular microstructure as an indicator of implant stability by using 2 cone beam computed tomography systems and micro-computed tomography Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2019 127 247 256 31 Tayman MA Kamburoğlu K Küçük Ö Ateş FS Günhan M Comparison of linear and volumetric measurements obtained from periodontal defects by using cone beam-CT and micro-CT: an in vitro study Clin Oral Investig 2019 23 2235 2244 32 Bathina S Das UN Resolvin D1 decreases severity of streptozotocin-induced type 1 diabetes mellitus by enhancing BDNF levels, reducing oxidative stress, and suppressing inflammation Int J Mol Sci 2021 22 1516 1529 33546300 33 Wu J Yan LJ Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicity Diabetes Metab Syndr Obes 2015 8 181 188 25897251 34 Mei YM Li L Wang XQ Zhang M Zhu LF Fu YW AGEs induces apoptosis and autophagy via reactive oxygen species in human periodontal ligament cells J Cell Biochem 2020 121 3764 3779 31680325 35 Kızıldağ A Arabacı T Albayrak M Balseven HM Aksu Kızıldağ C Tasdemir U A biochemical and immunohistochemical study of the effects of caffeic acid phenethyl ester on alveolar bone loss and oxidative stress in diabetic rats with experimental periodontitis Biotech Histochem 2020 95 456 463 32013634 36 Balci Yuce H Toker H Yildirim A Tekin MB Gevrek F Altunbas N The effect of luteolin in prevention of periodontal disease in Wistar rats J Periodontol. 2019 90 1481 1489 31115905 37 Yang D Liu R Liu L Liao H Wang C Cao Z Involvement of CD 147 in alveolar bone remodeling and soft tissue degradation in experimental periodontitis J Periodont Res 2017 52 704 712 38 Varela HA Souza JC Nascimento RM Araújo RF Vasconcelos RC Cavalcante RS Injectable platelet rich fibrin: Cell content, morphological, and protein characterization Clin Oral Investig 2019 23 1309 1318 39 Liao AM Jung H Yu JW Lee DH Park SS Cai B Synthesis and biological evaluation of arginyl–diosgenin conjugate as a potential bone tissue engineering agent Chem Biol Drug Des 2018 91 17 28 28643382 40 Ge Y Ding S Feng J Du J Gu Z Diosgenin inhibits Wnt/β-catenin pathway to regulate the proliferation and differentiation of MG-63 cells Cytotechnology 2021 73 169 178 33927474